Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection
Summary
Q-Plex™ multiplexing technology accurately detects antibodies and antigens in samples even at low concentrations, providing high specificity and sensitivity using a traditional ELISA protocol. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. Q-Plex™ multiplexing technology accurately detects antibodies and antigens in samples even at low concentrations, providing high specificity and sensitivity using a traditional ELISA protocol. Caymans Bioanalysis & Assay Development Services can also run clients samples using in-house chemiluminescent imager.To learn more about autoantibody reactivity to citrullinated, carbamylated, and/or native proteins and their link to early stages of certain inflammatory diseases and usefulness as biomarkers, our article Citrullination and Carbamylation in Inflammation and Autoimmunity: Key Biomarkers for Disease Detection reviews the analytes detected by this 10-plex panel.About Cayman ChemicalCayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards.